IP
Insight Pharmaceuticals
Resolving
Resolving brand mentions across new media
Insight Pharmaceuticals
Resolving brand mentions across new media
Insight Pharmaceuticals
Arcmira media summary
Browse Insight Pharmaceuticals interviews, podcasts & event videos — 1 indexed from GLOBAL IMMUNOTALKS, updated Dec 2025.
Acquired Essient Pharmaceuticals; developer of the MRGPRX2 antagonist EP001.
Arcmira tracks 1 indexed media appearances or mentions for Insight Pharmaceuticals, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes ""Sensing Inflammation at the Barrier" by Dr. Brian Kim" with transcript-derived context and links when available.
Insight Pharmaceuticals is connected to Poly-organic sensory neurons, Peripheral Neuroimmunology in Arcmira's media graph.
1
Mentions
1.4K
Views
The trendline is visible, but the dated evidence behind Insight Pharmaceuticals is in the premium layer.
“Acquired Essient Pharmaceuticals; developer of the MRGPRX2 antagonist EP001.”